NCT01281111View on ClinicalTrials.gov

Alternate Dosing Regimens of BG00012 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 1, 2011

Primary Completion Date

March 18, 2011

Study Completion Date

March 18, 2011

Conditions
Healthy
Interventions
DRUG

Dimethyl Fumarate (BG00012)

DRUG

Aspirin

DRUG

BG00012 matching placebo

DRUG

ASA matching placebo

Trial Locations (1)

55114

Research Site, Saint Paul

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY